(Q44410653)

2 December 2017

title

Effects of low dose tamoxifen on normal breast tissue from premenopausal women (English)

1 reference

2 December 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(02)00530-0

26 December 2023

7

Jordan VC

1 reference

2 December 2017

2

G. Facina

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706357

26 December 2023

author name string

Chein MB

4

1 reference

2 December 2017

G. R. de Lima

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706357

26 December 2023

J. Y. Shida

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706357

26 December 2023

M. B C. Chein

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706357

26 December 2023

P. Tanaka

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706357

26 December 2023

R. C. Dardes

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706357

26 December 2023

L. H. Gebrim

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706357

26 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12706357

26 December 2023

publication date

1 May 2003

1 reference

full work available at URL

2 December 2017

https://api.elsevier.com/content/article/PII:S0959804902005300?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(02)00530-0

https://api.elsevier.com/content/article/PII:S0959804902005300?httpAccept=text/plain

26 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(02)00530-0

European Journal of Cancer

26 December 2023

published in

1 reference

2 December 2017

volume

39

1 reference

2 December 2017

issue

7

1 reference

2 December 2017

page(s)

891-898

1 reference

Breast cancer prevention by antiestrogens

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

Biologic Activity of Tamoxifen at Low Doses in Healthy Women

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

Effect of tamoxifen on lipoprotein(a) and insulin-like growth factor-I (IGF-I) in healthy women

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

The clinical significance of error measurement in the interpretation of treatment results

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the Nationa

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

Phase III randomized trial of toremifene vs tamoxifen in hormonodependant advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. Swedish Breast Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

Effect of Tamoxifen on Bone Fractures in Older Nursing Home Residents

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

Effect of low dose tamoxifen on the insulin-like growth factor system in healthy women

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

Estrogen and progesterone receptor content in breast epithelial cells from healthy women during the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

Morphological evaluation of cell turnover in relation to the menstrual cycle in the “resting” human breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

Influence of menstrual cycle, parity and oral contraceptive use on steroid hormone receptors in normal breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

Oestrogen receptor expression in normal breast epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

The effect of 3-week tamoxifen treatment on oestrogen receptor levels in primary breast tumours: a flow cytometric study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

Changes in hormone receptors and proliferation markers in tamoxifen treated breast cancer patients and the relationship with response

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

Does tamoxifen change oestrogen and progesterone receptor expression in the endometrium and breast?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

Reduction in apoptosis relative to mitosis in histologically normal epithelium accompanies fibrocystic change and carcinoma of the premenopausal human breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

Tamoxifen induced apoptosis in ZR-75 breast cancer xenografts antedates tumour regression

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

Effect of a half dose of tamoxifen on proliferative activity in normal breast tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

Effects of tamoxifen on the breast in the luteal phase of the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

Estrogenic activity of tamoxifen on normal mammary parenchyma in the luteal phase of the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

Influence of the antioestrogen tamoxifen on normal breast tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900530-0

7 January 2021

A pilot study of the effects of short-term tamoxifen therapy on Ki-67 labelling index in women with primary breast cancer

21

1 reference

https://api.crossref.org/works/10.1016/S0959-8049(02)00530-0

26 December 2023

Identifiers

1 reference

2 December 2017

1 reference